Federated Hermes’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7
| Closed | -$270 | – | 2177 |
|
|
2024
Q4 | $270 | Buy |
+7
| New | +$270 | ﹤0.01% | 2048 |
|
|
2023
Q4 | – | Sell |
-60,234
| Closed | -$1M | – | 2175 |
|
|
2023
Q3 | $1M | Buy |
60,234
+30,507
| +103% | +$509K | ﹤0.01% | 1110 |
|
|
2023
Q2 | $821K | Buy |
29,727
+74
| +0.2% | +$2.04K | ﹤0.01% | 1200 |
|
|
2023
Q1 | $682K | Sell |
29,653
-17,155
| -37% | -$395K | ﹤0.01% | 1305 |
|
|
2022
Q4 | $511K | Buy |
+46,808
| New | +$511K | ﹤0.01% | 1362 |
|
|
2022
Q3 | – | Sell |
-28
| Closed | -$1K | – | 2223 |
|
|
2022
Q2 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 2071 |
|
|
2021
Q4 | – | Sell |
-131,282
| Closed | -$2.33M | – | 2286 |
|
|
2021
Q3 | $2.33M | Buy |
131,282
+69,267
| +112% | +$1.23M | ﹤0.01% | 1002 |
|
|
2021
Q2 | $2.78M | Buy |
+62,015
| New | +$2.78M | 0.01% | 994 |
|
|
2021
Q1 | – | Sell |
-42,992
| Closed | -$867K | – | 2328 |
|
|
2020
Q4 | $867K | Buy |
42,992
+42,887
| +40,845% | +$865K | ﹤0.01% | 1375 |
|
|
2020
Q3 | $2K | Buy |
+105
| New | +$2K | ﹤0.01% | 2103 |
|
|
2019
Q3 | – | Sell |
-304
| Closed | -$4K | – | 2274 |
|
|
2019
Q2 | $4K | Buy |
304
+130
| +75% | +$1.71K | ﹤0.01% | 2019 |
|
|
2019
Q1 | $2K | Buy |
+174
| New | +$2K | ﹤0.01% | 2070 |
|
|
2018
Q3 | – | Sell |
-12,682
| Closed | -$85K | – | 2313 |
|
|
2018
Q2 | $85K | Sell |
12,682
-51,239
| -80% | -$343K | ﹤0.01% | 1623 |
|
|
2018
Q1 | $549K | Buy |
63,921
+46,496
| +267% | +$399K | ﹤0.01% | 1368 |
|
|
2017
Q4 | $362K | Buy |
+17,425
| New | +$362K | ﹤0.01% | 1434 |
|